Bristol Myers Squibb Co Drug Patent Portfolio

Bristol Myers Squibb Co's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb Co News

Bristol Myers Squibb (BMS): Managing the Patent Expiration Challenge with an Enhanced Pipeline and Strategic Initiatives...

15 Dec, 2025

Will Label Expansions for Opdivo Support Bristol Myers' Continued Growth? - TradingView

12 Dec, 2025

Will Label Expansions for Opdivo Support Bristol Myers' Continued Growth?

12 Dec, 2025

Will Label Expansions for Opdivo Support Bristol Myers' Continued Growth? - Finviz

12 Dec, 2025

See More